Prevalence and Clinical Outcomes of Discordant Lesions Between Fractional Flow Reserve and Nonhyperemic Pressure Ratios in Clinical Practice: The J-PRIDE RegistryShoichi Kuramitsu, Hidenobu Terai, Hirohiko Ando et al.|Circulation|2025Cited by 20
Impact of Antiplatelet Therapy on 5-Year Outcomes After Fractional Flow Reserve-Guided Deferral of Revascularization in Nonsignificant Obstructive Coronary Artery DiseaseTairo Kurita, Shoichi Kuramitsu, Masanobu Ishii et al.|Circulation Reports|2024Cited by 2
Prognostic Impact of Definite and Marginal Discordance Between Fractional Flow Reserve and Nonhyperemic Pressure RatioYasutsugu Shiono, Nobuhiro Tanaka, Shoichi Kuramitsu et al.|JACC: Cardiovascular Interventions|2026Cited by 1
Prognostic Impact of Renal Function on Outcomes After Physiology-Guided Coronary Revascularization: Insights From the J-PRIDE RegistryHirofumi Ohashi, on behalf of the J-PRIDE investigators, Shoichi Kuramitsu et al.|Circulation Cardiovascular Interventions|2026Cited by 0
Clinical outcomes following fractional flow reserve-guided revascularization using nicorandil versus conventional hyperemic agents: insights from the J-PRIDE RegistryKazutaka Nogi, Daisuke Higashioka, Shoichi Kuramitsu et al.|Cardiovascular Intervention and Therapeutics|2026Cited by 0